(GMAB) Genmab AS - Performance -29.5% in 12m
Compare GMAB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-44.41%
#67 in Group
Rel. Strength
22.12%
#6232 in Universe
Total Return 12m
-29.52%
#77 in Group
Total Return 5y
-16.71%
#45 in Group
P/E 10.9
45th Percentile in Group
P/E Forward 11.1
44th Percentile in Group
PEG 1.06
83th Percentile in Group
FCF Yield 12.3%
98th Percentile in Group
12m Total Return: GMAB (-29.5%) vs XBI (-6.5%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
| LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
| ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
| GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: GMAB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GMAB
| Total Return (including Dividends) | GMAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 4.35% | -10.94% | -6.73% |
| 3 Months | -5.45% | -14.92% | -11.93% |
| 12 Months | -29.52% | -6.46% | 7.24% |
| 5 Years | -16.71% | -19.21% | 100.61% |
| Trend Score (consistency of price movement) | GMAB | XBI | S&P 500 |
| 1 Month | 23.2% | -52.8% | -63.5% |
| 3 Months | -29.9% | -92.8% | -90.3% |
| 12 Months | -90.0% | -32.4% | 60.6% |
| 5 Years | -56.3% | -53.3% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #37 | 17.2% | 11.9% |
| 3 Month | #52 | 11.1% | 7.35% |
| 12 Month | #77 | -24.7% | -34.3% |
| 5 Years | #47 | 3.09% | -58.5% |
FAQs
Does GMAB Genmab AS outperforms the market?
No,
over the last 12 months GMAB made -29.52%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months GMAB made -5.45%, while XBI made -14.92%.
Over the last 3 months GMAB made -5.45%, while XBI made -14.92%.
Performance Comparison GMAB vs Indeces and Sectors
GMAB vs. Indices GMAB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.11% | 11.1% | -4.67% | -36.8% |
| US NASDAQ 100 | QQQ | 0.63% | 11.7% | -4.81% | -37.1% |
| US Dow Jones Industrial 30 | DIA | 3.14% | 11.3% | -5.29% | -34.0% |
| German DAX 40 | DAX | -0.11% | 8.29% | -24.6% | -49.9% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.68% | 7.74% | -5.82% | -38.7% |
| Hongkong Hang Seng | HSI | -1.56% | 8.07% | -9.21% | -46.3% |
| India NIFTY 50 | INDA | -1.04% | 2.32% | -8.02% | -32.5% |
| Brasil Bovespa | EWZ | -3.16% | 3.89% | -9.72% | -20.8% |
GMAB vs. Sectors GMAB is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.40% | 11.2% | -13.8% | -44.6% |
| Consumer Discretionary | XLY | -0.33% | 11.2% | -9.97% | -40.8% |
| Consumer Staples | XLP | 0.96% | 1.37% | -12.6% | -40.9% |
| Energy | XLE | 1.04% | 16.9% | -3.37% | -16.8% |
| Financial | XLF | 0.41% | 9.20% | -13.5% | -47.4% |
| Health Care | XLV | 3.38% | 12.1% | -2.45% | -27.1% |
| Industrial | XLI | 1.71% | 10.4% | -4.50% | -33.6% |
| Materials | XLB | 1.37% | 10.2% | 2.59% | -23.6% |
| Real Estate | XLRE | 1.34% | 7.58% | -4.32% | -44.3% |
| Technology | XLK | 0.84% | 13.4% | 1.57% | -30.7% |
| Utilities | XLU | 1.22% | 4.15% | -8.30% | -51.2% |
| Aerospace & Defense | XAR | 2.56% | 7.53% | -14.0% | -51.4% |
| Biotech | XBI | -2.31% | 15.3% | 6.73% | -23.1% |
| Homebuilder | XHB | -0.42% | 12.5% | 10.1% | -19.0% |
| Retail | XRT | -0.76% | 9.74% | -1.23% | -23.2% |